Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
185.00
-2.40 (-1.28%)
At close: Apr 28, 2026, 4:00 PM EDT
186.40
+1.40 (0.76%)
Pre-market: Apr 29, 2026, 6:57 AM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $9.46 billion as of April 29, 2026. Its market cap has increased by 97.90% in one year.
Market Cap
9.46B
Enterprise Value
9.36B
1-Year Change
97.90%
Ranking
Category
Stock Price
$185.00
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $9.46B, an increase of 6,009.33%. That is a compound annual growth rate of 48.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.46B | 2.78% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ionis Pharmaceuticals | 11.93B |
| Madrigal Pharmaceuticals | 11.93B |
| Exelixis | 11.34B |
| BioMarin Pharmaceutical | 10.40B |
| Arrowhead Pharmaceuticals | 10.31B |
| Praxis Precision Medicines | 9.22B |
| ABIVAX Société Anonyme | 8.98B |
| Bio-Techne | 8.62B |